Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Sep;73(863):557–559. doi: 10.1136/pgmj.73.863.557

Creutzfeldt-Jakob disease in the elderly.

R de Silva 1, C Findlay 1, I Awad 1, R Harries-Jones 1, R Knight 1, R Will 1
PMCID: PMC2431436  PMID: 9373595

Abstract

Creutzfeldt-Jakob disease (CJD) is typically described as a pre-senile dementia. However, cases do occur in the elderly and a case of sporadic CJD in an 86-year-old patient is described. The database of the UK national surveillance unit has been studied, and the age-specific incidences for various age groups over the period 1980-93 calculated. Cases of CJD in those over 80 years old have been identified and their clinical characteristics examined. There is no evidence that CJD presents atypically in the elderly, or that large numbers of cases are being missed in the elderly due to poor ascertainment.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell J. E., Ironside J. W. Neuropathology of spongiform encephalopathies in humans. Br Med Bull. 1993 Oct;49(4):738–777. doi: 10.1093/oxfordjournals.bmb.a072645. [DOI] [PubMed] [Google Scholar]
  2. Brown P., Gibbs C. J., Jr, Rodgers-Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., Gajdusek D. C. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994 May;35(5):513–529. doi: 10.1002/ana.410350504. [DOI] [PubMed] [Google Scholar]
  3. Brown P., Kaur P., Sulima M. P., Goldfarb L. G., Gibbs C. J., Jr, Gajdusek D. C. Real and imagined clinicopathological limits of "prion dementia". Lancet. 1993 Jan 16;341(8838):127–129. doi: 10.1016/0140-6736(93)90001-w. [DOI] [PubMed] [Google Scholar]
  4. Esmonde T. G., Will R. G. Creutzfeldt-Jakob disease in Scotland and Northern Ireland 1980-1989. Scott Med J. 1992 Dec;37(6):181–184. doi: 10.1177/003693309203700607. [DOI] [PubMed] [Google Scholar]
  5. Hainfellner J. A., Jellinger K., Diringer H., Guentchev M., Kleinert R., Pilz P., Maier H., Budka H. Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):139–142. doi: 10.1136/jnnp.61.2.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jellinger K., Danielczyk W., Fischer P., Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci. 1990 Mar;95(3):239–258. doi: 10.1016/0022-510x(90)90072-u. [DOI] [PubMed] [Google Scholar]
  7. Westaway D., DeArmond S. J., Cayetano-Canlas J., Groth D., Foster D., Yang S. L., Torchia M., Carlson G. A., Prusiner S. B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 1994 Jan 14;76(1):117–129. doi: 10.1016/0092-8674(94)90177-5. [DOI] [PubMed] [Google Scholar]
  8. Will R. G., Matthews W. B. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):134–140. doi: 10.1136/jnnp.47.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES